INS and Other metabolic disease: These discrepancies may be explained by the evaluation of a group of patients of mixed metabolic disease statuses in these studies, complicating the evaluation of serum VEGF levels, as serum VEGF levels are induced by insulin and hyperglycemia (4,17).